$13.59-6.92%
2026-10-06 closeAvalo Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$69M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Avalo Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$69M.